Humphries

Review article: drug interactions with agents used to treat acid‐related diseases

T. Humphries, Merritt, Humphries, 1999, Alimentary pharmacology & therapeutics.

Comparison of rabeprazole 20 mg versus omeprazole 20 mg in the treatment of active duodenal ulcer: a European multicentre study

Dekkers, Bell, Humphries, 1999, Alimentary pharmacology & therapeutics.

Double‐blind, placebo‐controlled comparison of rabeprazole 20 mg vs. omeprazole 20 mg in the treatment of erosive or ulcerative gastro‐oesophageal reflux disease

Dekkers, Bell, Humphries, 1999 .

Comparison of rabeprazole 20 mg vs. omeprazole 20 mg in the treatment of active gastric ulcer—a European multicentre study

Dekkers, Bell, Humphries, 1998, Alimentary pharmacology & therapeutics.

An ascending single‐dose safety and tolerance study of an oral formulation of rabeprazole (E3810)

Walsh, Kovács, Lew, 1998, Alimentary pharmacology & therapeutics.

Rabeprazole produces rapid, potent, and long‐acting inhibition of gastric acid secretion in subjects with Helicobacter pylori infection

Walsh, Kovács, Sytnik, 2000, Alimentary pharmacology & therapeutics.

Review article: rabeprazole’s profile in patients with gastrointestinal diseases

Barth, Humphries, 1999, Alimentary pharmacology & therapeutics.